Indication
Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis
1 clinical trial
1 product
Product
LuspaterceptClinical trial
A Phase 3b, Open-label, Single-arm, Rollover Study to Evaluate Long-term Safety in Subjects Who Have Participated in Other Luspatercept (ACE-536) Clinical TrialsStatus: Recruiting, Estimated PCD: 2028-05-12